Detalhe da pesquisa
1.
Long-term results of Waldenström macroglobulinaemia treatment by bendamustine and rituximab: A study on behalf of the French Innovative Leukemia Organization (FILO).
Br J Haematol
; 204(6): 2233-2236, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38504454